Edition:
United Kingdom

People: Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

258.58USD
16 Sep 2019
Change (% chg)

$5.50 (+2.17%)
Prev Close
$253.08
Open
$252.50
Day's High
$260.28
Day's Low
$252.50
Volume
343,853
Avg. Vol
329,921
52-wk High
$317.89
52-wk Low
$227.22

Tallett, Elizabeth 

Ms. Elizabeth E. Tallett is Independent Chairman of the Board of Anthem, Inc., effective May 16, 2018. She has been a director of the Company since October 2013 and became independent Chair of the Board in May 2018. She was a principal of Hunter Partners, LLC (healthcare consulting) from 2002 to 2015. Ms. Tallett continues to operate as a consultant to healthcare companies. Previously, Ms. Tallett was President and Chief Executive Officer of Transcell Technologies, Inc. (specialty pharmaceuticals), President of Centocor Pharmaceuticals (biotechnology), member of the Parke-Davis (pharmaceuticals) Executive Committee and Director of Worldwide Strategic Planning for Warner-Lambert Company (pharmaceuticals). Ms. Tallett has served as a director of Meredith Corporation (magazine publisher) since 2008, Principal Financial Group, Inc. (financial services) since 1992 (as lead director since 2007) and Qiagen, N.V. (biotechnology research equipment manufacturing) since 2011. She previously served as a director of Coventry Health Care, Inc. (health insurance) from 1998 to 2013 (including serving as lead director).

Basic Compensation

Total Annual Compensation, USD 273,072
Restricted Stock Award, USD 174,997
Long-Term Incentive Plans, USD --
All Other, USD 6,500
Fiscal Year Total, USD 454,569

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --